Sergey Illarioshkin Selected Research

N-docosahexaenoyl dopamine

1/2021

Neuroprotective and neurotoxic effects of endocannabinoid-like compounds, N-arachidonoyl dopamine and N-docosahexaenoyl dopamine in differentiated cultures of induced pluripotent stem cells derived from patients with Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergey Illarioshkin Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2018
1	Glycogen Storage Disease Type II (Pompe's Disease) 12/2021
1	Myocardial Infarction 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Dystonic Disorders (Writer's Cramp) 10/2020
1	Deglutition Disorders (Dysphagia) 10/2020
1	Huntington Disease (Huntington's Disease) 01/2018
1	Gaucher Disease (Gaucher's Disease) 01/2018
1	CADASIL 02/2015
1	Infarction (Infarctions) 02/2015

Drug/Important Bio-Agent (IBA)

2	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2022 - 01/2021
1	GlycogenIBA 12/2021
1	human GAA protein (Myozyme)FDA Link 12/2021
1	AcidsIBA 12/2021
1	EnzymesIBA 12/2021
1	GlucosidasesIBA 12/2021
1	EndocannabinoidsIBA 01/2021
1	N-docosahexaenoyl dopamineIBA 01/2021
1	CannabinoidsIBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Type A Botulinum Toxins (Botox)FDA Link 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	SphingomyelinsIBA 01/2018
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2018
1	Calcium Channels (Calcium Channel)IBA 01/2018
1	CalciumIBA 01/2018
1	SphingolipidsIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Cysteine (L-Cysteine)FDA Link 02/2015

Therapy/Procedure

1	Enzyme Replacement Therapy 12/2021
1	Therapeutics 12/2021
1	Injections 10/2020